Premium
The government must provide incentives to encourage research and development in the active pharmaceutical ingredient (API) sector, especially considering that India lags far behind China in this area, according to panelists at the VCCircle Healthcare Summit 2025. “In 1991, our dependence (for API imports) on China was 71%. In 2021, ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.